
TheHannaGroup
@hannagroup_icl
@ImperialSandC lab led by @profgeorgehanna. We focus on volatile organic compounds (VOCs) as non-invasive markers of human disease. @imperialcollege
ID: 1603071340780683268
http://imperial.ac.uk/department-surgery-cancer/research/surgery/groups/volatile-biomarker-research-group/ 14-12-2022 16:57:01
97 Tweet
232 Followers
155 Following

Thanks to NHS Cancer Programme for inviting Michael Fadel to present PANACEA at the Innovation in Early Diagnosis of Cancer event, which aims to develop a breath test to detect multi-gastrointestinal cancers Surgery and Cancer NHS England SBRI Healthcare National Institute for Health and Care Research NIHR HealthTech Research Centre in IVD




The newly launched HealthTech Research Centre in In Vitro Diagnostics (NIHR HealthTech Research Centre in IVD) from Imperial College London Imperial NHS 💙 National Institute for Health and Care Research will support the development and adoption of diagnostics. Find out more ⬇️ imperial.ac.uk/news/261634/ne…


A new study, led by S&C and the NIHR HealthTech Research Centre in IVD and published in Frontiers - Medicine, introduces a novel framework for evaluating the value of #diagnostic technologies in healthcare. 🧵 Find out more⬇️ imperial.ac.uk/news/261733/re…



Honoured to host Prof. Jimmy So NUS Yong Loo Lin School of Medicine and share our work on VOCs for early cancer detection. Also great to learn from his insights on improving outcomes for gastric cancer with peritoneal metastasis Surgery and Cancer Imperial College London.



Our researchers Nayaab Abdul Kader and Dr Henry Robb Surgery and Cancer will be running the TCS London Marathon to raise money for Pancreatic Cancer UK Please support life-saving research by donating: 2025tcslondonmarathon.enthuse.com/pf/nayaab-abdu…


This week Imperial NHS 💙 performed first Gastric PIPAC treatment in England as part of PICCOS study following our colleagues in Wales. Massive team effort. Thanks to all those who supported it & most importantly the patients who put their trust in the trial Surgery and Cancer



[Paper Tweet-torial] Can VOCs be used to non-invasively monitor cancer therapy response? In our latest Nature Portfolio Scientific Reports study, we explore the volatilomic signatures of mTOR inhibitor resistance in colorectal cancer. 🔗 nature.com/articles/s4159… 1/n

Delighted to share our group's latest work on the potential of VOCs as surrogate biomarkers of targeted cancer therapy response. Well done to the team Philip Leung OG Surgery Surgery and Cancer Imperial Medicine Imperial College London


9/n Huge thanks to the team: Innah, Bibek OG Surgery, George Hanna Surgery and Cancer Imperial Medicine Imperial College London Read the full open access study here: nature.com/articles/s4159… Double celebration day: PhD Graduation + New Paper


